Nan J[Author] - Search Results

Year	Number of Results
1988	1
1992	1
1994	1
2000	5
2001	3
2002	5
2003	6
2004	2
2005	3
2006	5
2007	7
2008	9
2009	16
2010	27
2011	12
2012	18
2013	21
2014	23
2015	25
2016	29
2017	35
2018	43
2019	66
2020	77
2021	83
2022	106
2023	107
2024	36

1

Cytoskeleton remodeling mediated by circRNA-YBX1 phase separation suppresses the metastasis of liver cancer.

Liu B, Shen H, He J, Jin B, Tian Y, Li W, Hou L, Zhao W, Nan J, Zhao J, Shen J, Yu H, Wang Y, Shan G, Shi L, Cai X. Liu B, et al. Among authors: nan j. Proc Natl Acad Sci U S A. 2023 Jul 25;120(30):e2220296120. doi: 10.1073/pnas.2220296120. Epub 2023 Jul 17. Proc Natl Acad Sci U S A. 2023. PMID: 37459535 Free PMC article.

2

Reversal of liver failure using a bioartificial liver device implanted with clinical-grade human-induced hepatocytes.

Wang Y, Zheng Q, Sun Z, Wang C, Cen J, Zhang X, Jin Y, Wu B, Yan T, Wang Z, Gu Q, Lv X, Nan J, Wu Z, Sun W, Pan G, Zhang L, Hui L, Cai X. Wang Y, et al. Among authors: nan j. Cell Stem Cell. 2023 May 4;30(5):617-631.e8. doi: 10.1016/j.stem.2023.03.013. Epub 2023 Apr 13. Cell Stem Cell. 2023. PMID: 37059100 Free article.

3

The Hippo pathway kinases LATS1 and LATS2 attenuate cellular responses to heavy metals through phosphorylating MTF1.

Han H, Nakaoka HJ, Hofmann L, Zhou JJ, Yu C, Zeng L, Nan J, Seo G, Vargas RE, Yang B, Qi R, Bardwell L, Fishman DA, Cho KWY, Huang L, Luo R, Warrior R, Wang W. Han H, et al. Among authors: nan j. Nat Cell Biol. 2022 Jan;24(1):74-87. doi: 10.1038/s41556-021-00813-8. Epub 2022 Jan 13. Nat Cell Biol. 2022. PMID: 35027733 Free PMC article.

4

FMO2 ameliorates nonalcoholic fatty liver disease by suppressing ER-to-Golgi transport of SREBP1.

Ke C, Xiao C, Li J, Wu X, Zhang Y, Chen Y, Sheng S, Fu Z, Wang L, Ni C, Zhao J, Shi Y, Wu Y, Zhong Z, Nan J, Zhu W, Chen J, Wu R, Hu X. Ke C, et al. Among authors: nan j. Hepatology. 2023 Oct 24. doi: 10.1097/HEP.0000000000000643. Online ahead of print. Hepatology. 2023. PMID: 37874228

5

Cryo-EM structures of human organic anion transporting polypeptide OATP1B1.

Shan Z, Yang X, Liu H, Yuan Y, Xiao Y, Nan J, Zhang W, Song W, Wang J, Wei F, Zhang Y. Shan Z, et al. Among authors: nan j. Cell Res. 2023 Dec;33(12):940-951. doi: 10.1038/s41422-023-00870-8. Epub 2023 Sep 6. Cell Res. 2023. PMID: 37674011 Free PMC article.

6

Fundamentals of Cardiac Mapping.

Ladas TP, Sugrue A, Nan J, Vaidya VR, Padmanabhan D, Venkatachalam KL, Asirvatham SJ. Ladas TP, et al. Among authors: nan j. Card Electrophysiol Clin. 2019 Sep;11(3):433-448. doi: 10.1016/j.ccep.2019.05.005. Card Electrophysiol Clin. 2019. PMID: 31400868 Review.

7

A new generation M^pro inhibitor with potent activity against SARS-CoV-2 Omicron variants.

Huang C, Shuai H, Qiao J, Hou Y, Zeng R, Xia A, Xie L, Fang Z, Li Y, Yoon C, Huang Q, Hu B, You J, Quan B, Zhao X, Guo N, Zhang S, Ma R, Zhang J, Wang Y, Yang R, Zhang S, Nan J, Xu H, Wang F, Lei J, Chu H, Yang S. Huang C, et al. Among authors: nan j. Signal Transduct Target Ther. 2023 Mar 16;8(1):128. doi: 10.1038/s41392-023-01392-w. Signal Transduct Target Ther. 2023. PMID: 36928316 Free PMC article.

8

STAT2 hinders STING intracellular trafficking and reshapes its activation in response to DNA damage.

Wang C, Nan J, Holvey-Bates E, Chen X, Wightman S, Latif MB, Zhao J, Li X, Sen GC, Stark GR, Wang Y. Wang C, et al. Among authors: nan j. Proc Natl Acad Sci U S A. 2023 Apr 18;120(16):e2216953120. doi: 10.1073/pnas.2216953120. Epub 2023 Apr 10. Proc Natl Acad Sci U S A. 2023. PMID: 37036972 Free PMC article.

9

The gut microbes in inflammatory bowel disease: Future novel target option for pharmacotherapy.

Yuan S, Wang KS, Meng H, Hou XT, Xue JC, Liu BH, Cheng WW, Li J, Zhang HM, Nan JX, Zhang QG. Yuan S, et al. Among authors: nan jx. Biomed Pharmacother. 2023 Sep;165:114893. doi: 10.1016/j.biopha.2023.114893. Epub 2023 Jun 21. Biomed Pharmacother. 2023. PMID: 37352702 Free article. Review.

10

Stable Ischemic Heart Disease in Women.

Schmidt KMT, Nan J, Scantlebury DC, Aggarwal NR. Schmidt KMT, et al. Among authors: nan j. Curr Treat Options Cardiovasc Med. 2018 Aug 7;20(9):72. doi: 10.1007/s11936-018-0665-4. Curr Treat Options Cardiovasc Med. 2018. PMID: 30084006 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

679 results

Results by year

Search Page

Filters

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

Search Results

679 results

Results by year